These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36374569)

  • 1. Outpatient purchasing patterns of hydroxychloroquine and ivermectin in the USA and Canada during the COVID-19 pandemic: an interrupted time series analysis from 2016 to 2021.
    Ho M; Tadrous M; Iacono A; Suda K; Gomes T
    J Antimicrob Chemother; 2022 Dec; 78(1):242-251. PubMed ID: 36374569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in dispensing of medicines proposed for re-purposing in the first year of the COVID-19 pandemic in Australia.
    Schaffer AL; Henry D; Zoega H; Elliott JH; Pearson SA
    PLoS One; 2022; 17(6):e0269482. PubMed ID: 35704621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Twitter data to understand public perceptions of approved versus off-label use for COVID-19-related medications.
    Hua Y; Jiang H; Lin S; Yang J; Plasek JM; Bates DW; Zhou L
    J Am Med Inform Assoc; 2022 Sep; 29(10):1668-1678. PubMed ID: 35775946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From hydroxychloroquine to ivermectin: what are the anti-viral properties of anti-parasitic drugs to combat SARS-CoV-2?
    Rakedzon S; Neuberger A; Domb AJ; Petersiel N; Schwartz E
    J Travel Med; 2021 Feb; 28(2):. PubMed ID: 33480414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of Trump's Promotion of Unproven COVID-19 Treatments and Subsequent Internet Trends: Observational Study.
    Niburski K; Niburski O
    J Med Internet Res; 2020 Nov; 22(11):e20044. PubMed ID: 33151895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Misinformation, Trust, and Use of Ivermectin and Hydroxychloroquine for COVID-19.
    Perlis RH; Lunz Trujillo K; Green J; Safarpour A; Druckman JN; Santillana M; Ognyanova K; Lazer D
    JAMA Health Forum; 2023 Sep; 4(9):e233257. PubMed ID: 37773507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in Purchases for Intensive Care Medicines During the COVID-19 Pandemic: A Global Time Series Study.
    Callaway Kim K; Tadrous M; Kane-Gill SL; Barbash IJ; Rothenberger SD; Suda KJ
    Chest; 2021 Dec; 160(6):2123-2134. PubMed ID: 34389295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment?
    Patrì A; Fabbrocini G
    J Am Acad Dermatol; 2020 Jun; 82(6):e221. PubMed ID: 32283237
    [No Abstract]   [Full Text] [Related]  

  • 9. Outpatient prescription patterns of COVID-19 drugs in the metropolitan area of Mexico City.
    Fuentes-Gonzalez MF; Ordinola Navarro A; Carmona-Aguilera Z; Hernández-Jimenez CA; Benitez-Altamirano GM; Beltran-Ontiveros LD; Lopez-Vejar C; Ramirez-Hinojosa JP; Vera-Lastra O; Lopez Luis BA
    Fam Pract; 2022 May; 39(3):515-518. PubMed ID: 34910137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sales of "COVID kit" drugs and adverse drug reactions reported by the Brazilian Health Regulatory Agency.
    Hentschke-Lopes M; Botton MR; Borges P; Freitas M; Mancuso ACB; Matte U
    Cad Saude Publica; 2022; 38(7):e00001022. PubMed ID: 35894360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: An interrupted time series analysis.
    Sulis G; Batomen B; Kotwani A; Pai M; Gandra S
    PLoS Med; 2021 Jul; 18(7):e1003682. PubMed ID: 34197449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes associated with Hydroxychloroquine and Ivermectin in hospitalized patients with COVID-19: a single-center experience.
    Ferreira RM; Beranger RW; Sampaio PPN; Mansur Filho J; Lima RAC
    Rev Assoc Med Bras (1992); 2021 Oct; 67(10):1466-1471. PubMed ID: 35018977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
    Singh B; Ryan H; Kredo T; Chaplin M; Fletcher T
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013587. PubMed ID: 33624299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase 2 randomized study on chloroquine, hydroxychloroquine or ivermectin in hospitalized patients with severe manifestations of SARS-CoV-2 infection.
    Galan LEB; Santos NMD; Asato MS; Araújo JV; de Lima Moreira A; Araújo AMM; Paiva ADP; Portella DGS; Marques FSS; Silva GMA; de Sousa Resende J; Tizolim MR; Santos PL; Buttenbender SF; de Andrade SB; Carbonell RCC; Da Rocha JG; de Souza RGS; da Fonseca AJ
    Pathog Glob Health; 2021 Jun; 115(4):235-242. PubMed ID: 33682640
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients.
    Okumuş N; Demirtürk N; Çetinkaya RA; Güner R; Avcı İY; Orhan S; Konya P; Şaylan B; Karalezli A; Yamanel L; Kayaaslan B; Yılmaz G; Savaşçı Ü; Eser F; Taşkın G
    BMC Infect Dis; 2021 May; 21(1):411. PubMed ID: 33947344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial.
    Vallejos J; Zoni R; Bangher M; Villamandos S; Bobadilla A; Plano F; Campias C; Chaparro Campias E; Achinelli F; Guglielmone HA; Ojeda J; Medina F; Farizano Salazar D; Andino G; Ruiz Diaz NE; Kawerin P; Meza E; Dellamea S; Aquino A; Flores V; Martemucci CN; Vernengo MM; Martinez SM; Segovia JE; Aguirre MG
    Trials; 2020 Nov; 21(1):965. PubMed ID: 33234158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of misinformation on ivermectin internet searches and prescribing trends during COVID-19.
    Ostrovsky AM; Parikh C
    J Public Health (Oxf); 2023 Aug; 45(3):631-635. PubMed ID: 36542148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug treatment for COVID-19.
    Ohe M; Furuya K; Goudarzi H
    Drug Discov Ther; 2021 Mar; 15(1):39-41. PubMed ID: 33612572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of the rise and fall in COVID-19 cases with the social isolation index and early outpatient treatment with hydroxychloroquine and chloroquine in the state of Santa Catarina, southern Brazil: A retrospective analysis.
    Neves FS
    Travel Med Infect Dis; 2021; 41():102005. PubMed ID: 33667717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The global impact of COVID-19 on drug purchases: A cross-sectional time series analysis.
    Suda KJ; Kim KC; Hernandez I; Gellad WF; Rothenberger S; Campbell A; Malliart L; Tadrous M
    J Am Pharm Assoc (2003); 2022; 62(3):766-774.e6. PubMed ID: 35094929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.